The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them ...
Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.
Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of ...
Q3 2025 Earnings Call Transcript November 12, 2025 Autolus Therapeutics plc misses on earnings expectations. Reported EPS is ...
LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and ...
Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance a ...
A tailored approach with rapid needs assessment before and during implementation to address local testing site barriers in ...
A federal judge has ordered the Trump administration to release money for SNAP (Supplementary Nutritional Assistance Program) ...
Total net revenue of $13.9 million Net income of $2.0 million, or $0.21 net income per share basic Adjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments $32.6 million cash ...
ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...
Having more options is always better—until it's not. Doctors face this paradox daily when choosing treatment plans for ...